WATCH RELATED VIDEO Submit Merck stated that the company will not research additional clinical studies of suvorexant 10 mg, but will start manufacturing studies to advance the 10 mg dosage form. Advertisement © 2017 HNGN, All rights reserved. Do not reproduce without permission. Advertisement 0 COMMENTS CLOSE COMMENT Get HNGN's Top Stories Newsletter Everyweek You have already subscribed. Thank you.